Table 2 Subgroup analysis in testosterone and DHEA
Subgrouped by | No. of trials | WMD (95% CI) | P Value | P for heterogeneity | I2 (%) | P for between Subgroup heterogeneity |
|---|---|---|---|---|---|---|
Testosterone | ||||||
 total | 9 | -0.47[−0.76,-0.18] | 0.002 | 0.002 | 68 |  |
 Statin type |  |  |  |  |  | 0.86 |
  Simvastatin | 6 | -0.48 [−0.77, − 0.18] | 0.002 | 0.002 | 66 |  |
  Atorvastatin | 3 | −0.39 [−1.38, 0.61] | 0.45 | 0.007 | 80 |  |
 Contol type |  |  |  |  |  | 0.90 |
  Placebo | 5 | -0.39 [−0.86, 0.09] | 0.11 | 0.008 | 71 |  |
  Metformin | 3 | −0.43 [− 0.84, − 0.02] | 0.04 | 0.06 | 65 |  |
DHEA | ||||||
 total | 7 | −0.51 [− 0.97, − 0.05] | 0.03 | < 0.001 | 84 |  |
 Statin type |  |  |  |  |  | 0.79 |
  Simvastatin | 5 | −0.46 [−1.02, 0.09] | 0.10 | < 0.001 | 89 |  |
  Atorvastatin | 2 | −0.62 [−1.70, 0.45] | 0.25 | < 0.001 | 67 |  |
 Contol type |  |  |  |  |  | 0.70 |
  Placebo | 3 | −0.49 [−1.44, 0.46] | 0.31 | < 0.001 | 93 |  |
  Metformin | 3 | −0.70 [−1.20, − 0.21] | 0.005 | 0.15 | 47 |  |